interactions with semaglutide Drug Interactions: Safety Guide drug interactions with semaglutide How

GLP-1 medications have transformed the way we approach weight loss

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

By losing weight under medical supervision, patients can reduce inflammation, improve circulation, and strengthen their oral health

Published Online: July2025

We will continue to monitor the phenomenal up-take of GLP-1 drugs (recognizing its growing pipeline shown in the chart above) and patients perspectives of the use of these medications both those people prescribed them to treat medical obesity and those consumers willing to pay for them out-of-pocket

Four findings that matter for how we understand health this week.